source
- Report highlights 20 women reshaping biopharma across oncology and rare disease fieldsThe 2026 special report spotlights twenty women who are driving change in biopharma, covering areas such as oncology and rare diseases. The series, now in its eighth year, has recognized over 160…
- Weighing the risks of CAR T in autoimmune disease as Kyverna nears marketNot a month after reports of three deaths in autoimmune trials for Novartis' CAR T cell therapy ignited a debate about the use of these treatments in nonfatal diseases, Kyverna Therapeutics reporte…BioSpace · 17d ago↗ source
- Eli Lilly reports strongest weight-loss data yet; Sanofi and Regeneron secure $1 billion upfront deal